These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2232358)

  • 1. [Preparation and assessment of an animal model of Alzheimer's disease].
    Matsuda H; Kinuya K; Tsuji S; Terada H; Shiba K; Kojima K; Mori H; Sumiya H; Hisada K
    Kaku Igaku; 1990 Aug; 27(8):883-91. PubMed ID: 2232358
    [No Abstract]   [Full Text] [Related]  

  • 2. Bilateral symmetry of cholinergic deficits in Alzheimer's disease.
    Zubenko GS; Moossy J; Hanin I; Martinez AJ; Rao GR; Kopp U
    Arch Neurol; 1988 Mar; 45(3):255-9. PubMed ID: 3341949
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Choline acetyltransferase and acetylcholinesterase abnormalities in senile dementia: importance of biochemical measurements in human post-mortem brain specimens.
    Sorbi S; Antuono P; Amaducci L
    Ital J Neurol Sci; 1980 Mar; 1(2):75-83. PubMed ID: 7040296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biochemical changes in Alzheimer's disease-senile dementia: neurotransmitters in senile dementia of the Alzheimer's type.
    Davies P
    Res Publ Assoc Res Nerv Ment Dis; 1979; 57():153-66. PubMed ID: 33427
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experimental pharmacology of Alzheimer's disease].
    Miyoshi K; Ueki A
    Nihon Rinsho; 1985 Jul; 43(7):1423-7. PubMed ID: 3903265
    [No Abstract]   [Full Text] [Related]  

  • 6. [Alzheimer-type dementia. Possible relation to hypofunction of the cholinergic central nervous system].
    Mellgren SI
    Tidsskr Nor Laegeforen; 1980 Aug; 100(23):1355-6. PubMed ID: 7456014
    [No Abstract]   [Full Text] [Related]  

  • 7. Alzheimer-like cholinergic deficiency in Down syndrome.
    Yates CM; Simpson J; Maloney AF; Gordon A; Reid AH
    Lancet; 1980 Nov; 2(8201):979. PubMed ID: 6107618
    [No Abstract]   [Full Text] [Related]  

  • 8. Alzheimer's disease and the new neuroscience.
    Wortis J
    Biol Psychiatry; 1983 Aug; 18(8):847-8. PubMed ID: 6137248
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effects of Chinese herb compound Naoyikang on expression of choline acetyltransferase in brain of rats with Alzheimer's disease].
    Geng JS; Zhou AL; Shi HY; Hu YE; Mao JH; Zhu Y
    Zhongguo Zhong Yao Za Zhi; 2008 May; 33(9):1071-4. PubMed ID: 18652361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alzheimer's disease: choline acetyltransferase activity in brain tissue from clinical and pathological subgroups.
    Bird TD; Stranahan S; Sumi SM; Raskind M
    Ann Neurol; 1983 Sep; 14(3):284-93. PubMed ID: 6227276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regional stimulation of cholinergic function by nerve growth factor in an animal model of Alzheimer's disease.
    Williams LR; Jodelis KS; Donald MR
    Prog Clin Biol Res; 1989; 317():1179-92. PubMed ID: 2602407
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholinergic markers in Alzheimer disease.
    Bartus RT; Emerich DF
    JAMA; 1999 Dec; 282(23):2208-9. PubMed ID: 10605966
    [No Abstract]   [Full Text] [Related]  

  • 13. Nucleus basalis (Ch4) and cortical cholinergic innervation in the human brain: observations based on the distribution of acetylcholinesterase and choline acetyltransferase.
    Mesulam MM; Geula C
    J Comp Neurol; 1988 Sep; 275(2):216-40. PubMed ID: 3220975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Challenging the cholinergic hypothesis in Alzheimer disease.
    Davies P
    JAMA; 1999 Apr; 281(15):1433-4. PubMed ID: 10217061
    [No Abstract]   [Full Text] [Related]  

  • 15. The cholinergic system in Alzheimer's disease.
    Kása P; Rakonczay Z; Gulya K
    Prog Neurobiol; 1997 Aug; 52(6):511-35. PubMed ID: 9316159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Micromethods in the determination of choline acetyltransferase, acetylcholinesterase and butyrylcholinesterase in brain tissue].
    Skopec F
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1988; 31(4):511-21. PubMed ID: 3249935
    [No Abstract]   [Full Text] [Related]  

  • 17. Alzheimer's disease and Down's syndrome.
    Price DL; Whitehouse PJ; Struble RG; Coyle JT; Clark AW; Delong MR; Cork LC; Hedreen JC
    Ann N Y Acad Sci; 1982; 396():145-64. PubMed ID: 6217772
    [No Abstract]   [Full Text] [Related]  

  • 18. Water intake and brain choline-acetyltransferase and acetylcholinesterase activites in manganese treated rats.
    Martínez H; Bonilla E
    Neurobehav Toxicol Teratol; 1981; 3(3):277-80. PubMed ID: 7290282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble and membrane-bound forms of brain acetylcholinesterase in Alzheimer's disease.
    Schegg KM; Harrington LS; Neilsen S; Zweig RM; Peacock JH
    Neurobiol Aging; 1992; 13(6):697-704. PubMed ID: 1491735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of acetylcholine hydrolase and choline acetyltransferase in rat brain after prolonged lysine vasopressin administration.
    Szadowska A; Szmigielska H; Szmigielski A; Mazur M
    Agressologie; 1981; 22(1):9-11. PubMed ID: 7294280
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.